Skip to main content
SpringerLink
Log in

Malignant Lymphoma in Children

  • Chapter
  • First Online:
Book cover Atlas of PET/CT in Pediatric Patients

  • 4507 Accesses

Abstract

This present chapter is dedicated to childhood and adolescence lymphomas, both Hodgkin’s (HL) and non-Hodgkin’s (NHL). Classical HL accounts for nearly 45 % of pediatric lymphomas. NHL accounts for about 55 % of all pediatric lymphomas: most common NHL subtypes are Burkitt’s lymphoma, lymphoblastic lymphoma, anaplastic large cell lymphoma, and diffuse large B-cell lymphoma. For each lymphoma subtype, an overview is given of epidemiology and histological characteristics. Clinical presentation and therapeutic strategies are also briefly summarized.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Horner MJ, Ries LAG, Krapcho M (2008) Cancer in children (ages 0–14 and ages 0–19). SEER Cancer Statistics Review, 1975–2006. National Cancer Institute, Bethesda

    Google Scholar 

  2. Hochberg J, Waxman IM, Kelly KM et al (2009) Adolescent non-Hodgkin lymphoma and Hodgkin lymphoma: state of the science. Br J Haematol 144:24–40

    Article  PubMed  Google Scholar 

  3. Carbone PP, Kaplan HS, Musshoff K et al (1971) Report of the committee on Hodgkin’s disease staging classification. Cancer Res 31:1860–1861

    PubMed  CAS  Google Scholar 

  4. Lister TA, Crowther D, Sutcliffe SB et al (1989) Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin’s disease: Cotswolds meeting. J Clin Oncol 7:1630–1636

    PubMed  CAS  Google Scholar 

  5. Donaldson SS (2002) Pediatric Hodgkin’s disease – up, up, and beyond. Int J Radiat Oncol Biol Phys 54:1–8

    Article  PubMed  Google Scholar 

  6. Bonadonna G, Zucali R, Monfardini S et al (1975) Combination chemotherapy of Hodgkin’s disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP. Cancer 36:252–259

    Article  PubMed  CAS  Google Scholar 

  7. Nachman JB, Sposto R, Herzog P et al (2002) Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin’s disease who achieve a complete response to chemotherapy. J Clin Oncol 20:3765–3771

    Article  PubMed  Google Scholar 

  8. Yung L, Smith P, Hancock BW et al (2004) Long term outcome in adolescents with Hodgkin’s lymphoma: poor results using regimens designed for adults. Leuk Lymphoma 45:1579–1585

    Article  PubMed  CAS  Google Scholar 

  9. Murphy SB (1978) Childhood non-Hodgkin’s lymphoma. N Engl J Med 299:1446–1448

    Article  PubMed  CAS  Google Scholar 

  10. Murphy SB (1980) Classification, staging and end results of treatment of childhood non-Hodgkin’s lymphomas: dissimilarities from lymphomas in adults. Semin Oncol 7:332–339

    PubMed  CAS  Google Scholar 

  11. Reiter A (2007) Diagnosis and treatment of childhood non-hodgkin lymphoma. Hematology Am Soc Hematol Educ Program 2007(1):285–296. doi: 10.1182/asheducation-2007.1.285

    Article  Google Scholar 

  12. Anderson JR, Jenkin RD, Wilson JF et al (1993) Long-term follow-up of patients treated with COMP or LSA2L2 therapy for childhood non-Hodgkin’s lymphoma: a report of CCG-551 from the Childrens Cancer Group. J Clin Oncol 11:1024–1032

    PubMed  CAS  Google Scholar 

  13. de-Thé G (1985) The Epstein-Barr virus (EBV): a Rosetta Stone for understanding the role of viruses in immunopathological disorders and in human carcinogenesis. Biomed Pharmacother 39:49–51

    PubMed  Google Scholar 

  14. Molyneux EM, Rochford R, Griffin B et al (2012) Burkitt’s lymphoma. Lancet 379:1234–1244

    Article  PubMed  Google Scholar 

  15. Bellan C, Lazzi S, Hummel M et al (2005) Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas. Blood 106:1031–1036

    Article  PubMed  CAS  Google Scholar 

  16. El-Mallawany NK, Frazer JK, Van Vlierberghe P et al (2012) Pediatric T- and NK-cell lymphomas: new biologic insights and treatment strategies. Blood Cancer J 2:e65

    Article  PubMed  CAS  Google Scholar 

  17. Schrappe M, Reiter A, Ludwig WD et al (2000) Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group. Blood 95:3310–3322

    PubMed  CAS  Google Scholar 

  18. Pillon M, Piglione M, Garaventa A et al (2009) Long-term results of AIEOP LNH-92 protocol for the treatment of pediatric lymphoblastic lymphoma: a report of the Italian Association of Pediatric Hematology and Oncology. Pediatr Blood Cancer 53:953–959

    Article  PubMed  Google Scholar 

  19. Burkhardt B, Woessmann W, Zimmermann M et al (2006) Impact of cranial radiotherapy on central nervous system prophylaxis in children and adolescents with central nervous system-negative stage III or IV lymphoblastic lymphoma. J Clin Oncol 24:491–499

    Article  PubMed  Google Scholar 

  20. Abromowitch M, Sposto R, Perkins S et al (2008) Shortened intensified multi-agent chemotherapy and non-cross resistant maintenance therapy for advanced lymphoblastic lymphoma in children and adolescents: report from the Children’s Oncology Group. Br J Haematol 143:261–267

    Article  PubMed  CAS  Google Scholar 

  21. Bureo E, Ortega JJ, Muñoz A et al (1995) Bone marrow transplantation in 46 pediatric patients with non-Hodgkin’s lymphoma. Spanish Working Party for Bone Marrow Transplantation in Children. Bone Marrow Transplant 15:353–359

    Article  PubMed  CAS  Google Scholar 

  22. Kleiner S, Kirsch A, Schwaner I et al (1997) High-dose chemotherapy with carboplatin, etoposide and ifosfamide followed by autologous stem cell rescue in patients with relapsed or refractory malignant lymphomas: a phase I/II study. Bone Marrow Transplant 20:953–959

    Article  PubMed  CAS  Google Scholar 

  23. Kobrinsky NL, Sposto R, Shah NR et al (2001) Outcomes of treatment of children and adolescents with recurrent non-Hodgkin’s lymphoma and Hodgkin’s disease with dexamethasone, etoposide, cisplatin, cytarabine, and l-asparaginase, maintenance chemotherapy, and transplantation: Children’s Cancer Group Study CCG-5912. J Clin Oncol 19:2390–2396

    PubMed  CAS  Google Scholar 

  24. Duyster J, Bai RY, Morris SW (2001) Translocations involving anaplastic lymphoma kinase (ALK). Oncogene 20:5623–5637

    Article  PubMed  CAS  Google Scholar 

  25. Benharroch D, Meguerian-Bedoyan Z, Lamant L et al (1998) ALK-positive lymphoma: a single disease with a broad spectrum of morphology. Blood 91:2076–2084

    PubMed  CAS  Google Scholar 

  26. Seidemann K, Tiemann M, Schrappe M et al (2001) Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90. Blood 97:3699–3706

    Article  PubMed  CAS  Google Scholar 

  27. Rosolen A, Pillon M, Garaventa A et al (2005) Anaplastic large cell lymphoma treated with a leukemia-like therapy: report of the Italian Association of Pediatric Hematology and Oncology (AIEOP) LNH-92 protocol. Cancer 104:2133–2140

    Article  PubMed  CAS  Google Scholar 

  28. Alizadeh AA, Eisen MB, Davis RE et al (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403:503–511

    Article  PubMed  CAS  Google Scholar 

  29. Oschlies I, Klapper W, Zimmermann M et al (2006) Diffuse large B-cell lymphoma in pediatric patients belongs predominantly to the germinal-center type B-cell lymphomas: a clinicopathologic analysis of cases included in the German BFM (Berlin-Frankfurt-Munster) Multicenter Trial. Blood 107:4047–4052

    Article  PubMed  CAS  Google Scholar 

  30. Patte C, Auperin A, Gerrard M et al (2007) Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients. Blood 109:2773–2780

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Nuclear Medicine Department, Sant’Andrea Hospital, Faculty of Medicine and Psychology, “Sapienza” University of Rome, Via di Grottarossa 1035-1039, Rome, 00189, Italy

    Francesco Cicone

  2. Pathology Department, Sant’Andrea Hospital, Faculty of Medicine and Psychology, “Sapienza” University of Rome, Via di Grottarossa 1035-1039, Rome, 00189, Italy

    Stefania Uccini MD

Authors
  1. Francesco Cicone
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stefania Uccini MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Francesco Cicone .

Editor information

Editors and Affiliations

  1. Nuclear Medicine, Positron Emission Tomography Centre, Torino, Italy

    Angelina Cistaro

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Italia

About this chapter

Cite this chapter

Cicone, F., Uccini, S. (2014). Malignant Lymphoma in Children. In: Cistaro, A. (eds) Atlas of PET/CT in Pediatric Patients. Springer, Milano. https://doi.org/10.1007/978-88-470-5358-8_5

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-5358-8_5

  • Published:

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-5357-1

  • Online ISBN: 978-88-470-5358-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation